Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

NCT07522151 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

874

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Gastric or Gastroesophageal Junction Cancer

Interventions

DRUG: Adebrelimab plus S-1 and oxaliplatin
DRUG: Adebrelimab blank preparation plus S-1 and oxaliplatin.

Sponsor

Shanghai Shengdi Pharmaceutical Co., Ltd